Korean J Androl.
2000 Dec;18(3):225-227.
Intracavernosal Needle breakage developed during Self-injection of Vasoactive Agent : Two case reports
- Affiliations
-
- 1Dr. Cha's Urology Clinic.
- 2Department of Urology, College of Medicine, Dong-A University.
- 3Pusan National University, Pusan, Korea.
Abstract
- Currently intracavernous pharmacotherapy is the second common therapeutic modality for erectile dysfunction after the introduction of Viagra. Nevertheless, intracavernous pharmacotherapy has increased in popularity for the past 15 years. While having an overwhelming safety after complete training in injection method, this treatment option can reveal unexpected complications related to self-injection. We report two cases of intracavernous needle breakage associated with alprostadil (Caverject , Pharmacia-Upjohn) and trimix self-injection therapy with a brief review of the literature.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Intracorporeal Needle Breakage during Intracavernous Self-injection of Vasoactive Agent: A Case Report
- A Case of Intracavernous Needle Breakage during Intracavernous Self-injection of Prostaglandin E1 ( Caverject? )
- A Case of Priapism Resulted in Severe Corporal Fibrosis by Abuse of Intracavernosal Self-injection
- Prostaglandin E1 (Alprostadil) Intracavernosal Self-Injection Therapy in Erectile Dysfunction
- Trimix Intracavernosal Injection Therapy in the Patients with Erectile Dysfunction
